AARDEX Group

AARDEX Group is invited as a guest speaker at the 2019 ASCPT

ascpt
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019

Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019 ANNUAL MEETING of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), Washington, March 13-16, 2019.

During the session ” Implementing Adherence Programs in Drug Development and Post Approval Settings” follow is intervention “Insights From Monitoring Adherence in Clinical Trials and in Clinical Care: Understanding the Key Question of Drug Forgiveness” 

Visit the website at: https://www.ascpt.org/Meetings/Annual-Meeting

Share This Post

You may also like...

Adherence - Guide for Sponsors and CROs
Breaking News

Electronic monitoring in clinical trials: a guide for sponsors and CROs

Clinical trials rely on accurate data. But what if one of the most important variables whether a patient actually takes the medication is based on guesswork? Traditional methods like pill counts, diaries, or verbal confirmation have long been the standard,

Medication adherence data in clinical trial dashboard
Breaking News

How poor adherence skews clinical trial results and what to do about it

Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In